Lv5
1420 积分 2024-09-06 加入
CLASP IID Trial and Registry
14小时前
已完结
Use of Amplatzer vascular plugs and Amplatzer duct occluder II additional sizes for occlusion of patent ductus arteriosus: A multi‐institutional study
7天前
已完结
Outcome after transcatheter occlusion of patent ductus arteriosus in infants less than 6 kg: A national study from United Kingdom and Ireland
8天前
已完结
Minimally invasive delivery of engineered heart tissues restores cardiac function in rats with chronic myocardial infarction
21天前
已完结
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial
29天前
已完结
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial
29天前
已完结
First‐in‐man study of a thinner‐strut sirolimus‐eluting bioresorbable scaffold (FUTURE‐I): Three‐year clinical and imaging outcomes
29天前
已完结
[The safety and efficacy of Firesorb bioresorbable scaffold in first-in-man study for coronary artery disease: the four-year outcomes]
29天前
已完结
Twelve-month angiographic and clinical outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold and a metallic stent in patients with coronary artery disease
1个月前
已完结
5-Year Outcomes With a Novel Coronary Sirolimus-Eluting Bioresorbable Scaffold
1个月前
已完结
皖公网安备34019202002308
